Biotrial

Biotrial is a clinical research organization specializing in drug development, providing comprehensive services for pharmaceutical and biotechnology companies. Their expertise encompasses preclinical and clinical development, ensuring effective support for drug trials across various therapeutic areas. Founded in 1989 in Rennes, France, Biotrial is a clinical research organization offering a range of services for drug development. Under the leadership of CEO François Peaucelle, the company has maintained a focus on expanding its clinical and bioanalytical capabilities.

Biotrial does not have any known subsidiaries or parent companies. Biotrial offers a comprehensive suite of clinical research services, with a strong emphasis on drug development. Their core offerings include preclinical pharmacology and clinical development services encompassing Phase I studies with healthy volunteers and specialized patient populations, as well as bioanalysis and biometrics. The company specializes in various therapeutic areas, including oncology, and utilizes advanced methodologies such as ECG, CNS testing, and imaging core lab services.

Biotrial tailors its solutions to meet the specific needs of biotechnology and pharmaceutical companies, thereby facilitating their drug development processes. Their services are accessible to clients across North America, Europe, and other global markets where they conduct studies, ensuring a broad reach within the industry. Biotrial generates revenue through a structured service model centered on B2B transactions with pharmaceutical and biotechnology firms. The company operates on a project-based pricing structure, where clients engage in contracts for specific research services such as clinical trial management and bioanalytical support.

This transactional framework allows for tailored agreements based on the complexity and requirements of each study, ensuring that clients receive bespoke solutions. While specific pricing plans for services are not publicly detailed, the company's offerings encompass flagship services that are integral to the drug development lifecycle, positioning Biotrial as a vital partner for its clients in navigating the research and regulatory landscape.